Amyotrophic Lateral Sclerosis Genetic Access Program: Paving the Way for Genetic Characterization of ALS in the Clinic.
Jennifer RoggenbuckKelly A RichLeah ViciniMarilly PalettasJoceyln SchroederChristina ZaleskiTara LincolnLuke DruryJonathan D GlassPublished in: Neurology. Genetics (2021)
The ALS GAP program provided a genetic diagnosis to ∼1 in 3 participants and may serve as a model for clinical genetic testing in ALS.